Aclarion adds to strong patent portfolio with notice of allowance for new u.s. patent application addressing key pain indicator biomarker

Strengthens portfolio by addressing the anaerobic bacteria that can seed into the intervertebral disc, proliferate, and accelerate painful disc degeneration.

ACON Ratings Summary

ACON Quant Ranking